Hemo-Dial C313BX
by Edlaw Pharmaceuticals, Inc.
Hemo-Dial C313BX is a haemodialysis concentrate (FDA Class II; FDA product code KPO, Dialysate Concentrate For Hemodialysis (Liquid Or Powder)) made by Edlaw Pharmaceuticals, Inc., cleared under FDA 510(k) K813388 on 31 Dec 1981 and listed in FDA GUDID since 23 Sep 2016 (UDI-DI 10857940006206), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10857940006206 | Date23 Sep 2016 | StatusListed |
| United States | FDA 510(k)SESE | NumberK813388 | Date31 Dec 1981 | StatusActive |
Official records
- AccessGUDID record 10857940006206
- FDA 510(k) database K813388
From the FDA record
- Device description
- CALCIUM CHLORIDE USP 31.3 GRAM PACKETS - HEMODIALYSATE ADDITIVE - 1 mEq/L INCREASE WHEN ADDED TO 9.46 LITERS (2.5 GALLONS) IN A 45X PROPORTIONING SYSTEM
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K813388 decided 31 Dec 1981 Active
- FDA GUDID UDI-DI 10857940006206 listed 23 Sep 2016 Listed
Timeline
- Cleared FDA 510(k) K813388
- Listed FDA GUDID 10857940006206
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Hemo-Dial
- Generic name
- Haemodialysis concentrate
- Model / Ref / Catalog
- C313BX
- Primary DI / UDI-DI
- 10857940006206
- 510(k) Number
- FDA product code
- KPO
- GMDN term
- Haemodialysis concentrate
- Device class
- Class II
- Regulation number
- 876.5820
- GUDID distribution status
- In Commercial Distribution
- Size
- Weight — 4.1 Pound
Similar devices
Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).
- ACETATE CONCENTRATES FOR HEMODIALYSIS by Medical Components, Inc.
- FRESENIUS DIALYSATE ACID CONCENTRATE by Fresenius Usa, Inc.
- NXSTAGE PUREFLOW SOLUTION by NxStage Medical, Inc.
- Isopure Dry Acid Dissolution System by Isopure, Corp.
- SODIUM BICARBONATE POWDER/BICARBONATE HEMODIALYSIS by American Healthcare, Inc.
- BICARBONATE CONCENTRATE POWDER by Haemolyte, Inc.
- DIALYSATE CONCENTRATE FOR HEMODIALYSIS by Cobe Laboratories, Inc.
- BIASOL LIQUID CONCENTRATES, ADD'L ACID CONCENTRATE by Baxter Healthcare Corp
- HEMODIALYSIS CONCENTRATE SOLUTION by Mid Atlantic Nephrology Center
- DRYALYSATE CONCENTRATE by Advanced Renal Technologies, Inc.